Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.

Li W, Zhang X, Huang Y, Guo Y, Zhang H, Ge W, Xie Y, Li Y, Zhou Z, Ni W, Zheng Z, Li J, Zhao Y

Open source

DOI: 10.1186/s12951-026-04617-6
Published: 2026 Jun 6
Container: Journal of nanobiotechnology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12951-026-04617-6,
  title = {Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.},
  author = {Li W and Zhang X and Huang Y and Guo Y and Zhang H and Ge W and Xie Y and Li Y and Zhou Z and Ni W and Zheng Z and Li J and Zhao Y},
  year = {2026},
  journal = {Journal of nanobiotechnology},
  doi = {10.1186/s12951-026-04617-6},
  url = {https://doi.org/10.1186/s12951-026-04617-6}
}

RIS

TY  - JOUR
TI  - Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.
AU  - Li W
AU  - Zhang X
AU  - Huang Y
AU  - Guo Y
AU  - Zhang H
AU  - Ge W
AU  - Xie Y
AU  - Li Y
AU  - Zhou Z
AU  - Ni W
AU  - Zheng Z
AU  - Li J
AU  - Zhao Y
PY  - 2026
JO  - Journal of nanobiotechnology
DO  - 10.1186/s12951-026-04617-6
UR  - https://doi.org/10.1186/s12951-026-04617-6
ER  -

APA

W, L., X, Z., Y, H., Y, G., H, Z., W, G., Y, X., Y, L., Z, Z., W, N., Z, Z., J, L., & Y, Z. (2026). Copper-EGCG nanoreactor orchestrates dual-metabolic assault and self-amplified cuproptosis for immunogenic prostate cancer therapy.. Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04617-6

Source records

pubmed · retrieved 2026-09-27T00:45:05.760Z
europe-pmc · retrieved 2026-09-27T00:45:05.769Z
doaj · retrieved 2026-09-27T00:45:05.770Z